• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

35.9400 USD 0.1500 0.42%

As of 20:10:00 ET on 11/21/2014.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 36.7000 Day's Range: 35.8000 - 36.8400 Volume: 465,410
Previous Close: 36.0900 52wk Range: 27.5100 - 39.9450 1-Yr Rtn: +5.03%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 35.9400
  • 1D
  • 1M
  • 1Y
36.0900
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 57.5464
Estimated P/E(12/2014) 34.0987
Relative P/E vs. SPX 3.1461
Earnings Per Share (USD) (ttm) 0.6245
Est. EPS (USD) (12/2014) 1.0540
Est. PEG Ratio 0.7577
Market Cap (M USD) 1,507.61
Shares Outstanding (M) 41.95
30 Day Average Volume 527,930
Price/Book (mrq) 2.8342
Price/Sale (ttm) 3.9121
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil